Trial
NCT03555448
Once Daily Immunosuppression Regimen
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Veloxis Pharmaceuticals
Condition
Kidney Transplant
Intervention
Once daily immunosuppression regimen
Why stopped
poor recruitment during pandemic and after
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-22